Rising KashmirRising KashmirRising Kashmir
  • Home
  • Top Stories
  • News
    • Kashmir
    • City
    • Jammu
    • Politics
  • National
  • Health
  • Anchor
  • Features
  • Interview
  • Video
  • Sports
Search

Archives

  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022

Categories

  • Anchor
  • Breaking
  • Business
  • City
  • Developing Story
  • Editorial
  • Education
  • Features
  • Health
  • Interview
  • Jammu
  • Jammu and Kashmir News
  • Kashmir
  • Kashmir Tourism
  • Kath Bath
  • National
  • Opinion
  • Politics
  • SEO
  • Sports
  • Technology
  • Top Stories
  • Trending
  • Uncategorized
  • Video
  • Viewpoint
  • World
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Reading: New medicine discovered to be beneficial for treating complicated urinary tract infections
Share
Notification Show More
Font ResizerAa
Rising KashmirRising Kashmir
Font ResizerAa
  • Home
  • Top Stories
  • News
  • National
  • Health
  • Anchor
  • Features
  • Interview
  • Video
  • Sports
Search
  • Top Stories
    • Developing Story
    • Anchor
    • Breaking
    • Business
    • Editorial
    • Education
    • Features
    • Health
    • Interview
  • More
    • National
    • Politics
    • Opinion
    • Technology
    • Sports
    • Trending
    • World
  • Kashmir
    • City
    • Jammu
    • Jammu and Kashmir News
    • Kashmir Tourism
    • Kath Bath
    • Video
    • Viewpoint
Follow US
© 2024. All Rights Reserved.
Rising Kashmir > Blog > Breaking > New medicine discovered to be beneficial for treating complicated urinary tract infections
Breaking

New medicine discovered to be beneficial for treating complicated urinary tract infections

ANI
Last updated: October 30, 2022 3:22 pm
ANI
Published: October 30, 2022
Share
4 Min Read
SHARE
Follow us on

According to an international study conducted by a Rutgers expert comparing new and older medicines for complicated urinary tract infections, a new medicine combination has been found to be more effective, particularly against chronic, drug-resistant infections.

Describing the results in the Journal of the American Medical Association (JAMA), researchers in the ALLIUM Phase 3 clinical trial showed that a combination of the drugs cefepime and enmetazobactam was more effective in treating both complicated urinary tract infections and acute pyelonephritis (AP), a bacterial infection causing kidney inflammation, than a standard treatment combining piperacillin and tazobactam. Urinary tract infections are considered complicated when they are associated with risk factors – including fevers, sepsis, urinary obstruction or catheters – that increase the danger of failing antibiotic therapy. “This new antibiotic was superior to the standard-of-care therapy,” said Keith Kaye, chief of the Division of Allergy, Immunology and Infectious Diseases and a professor of medicine at Rutgers Robert Wood Johnson Medical School.

“It represents an exciting option for treatment,” said Kaye, the principal investigator of the study and lead author on the publication.

Kaye added this drug combination also fights an often-dangerous category of bacterial illnesses caused by pathogens known as extended spectrum beta-lactamase (ESBL) infections, named for an enzyme the bacteria produce. ESBL-producing bacteria can’t be killed effectively by many of the antibiotics conventionally used to treat infections, such as penicillins and cephalosporins.

“We are looking for antibiotics that are active against resistant bacteria, such as ESBLs, and we found this new combination to be highly effective,” Kaye said.

The trial was conducted at 90 sites in Europe, North and Central America, South America and South Africa from September 2018 to November 2019. More than 1,000 patients participated in the study. Some 79 percent of the patients receiving the new combination of cefepime and enmetazobactam were successfully treated for their illness, as opposed to 58.9 percent of those receiving the conventional treatment of piperacillin and tazobactam.

Of the 20 percent of patients from the overall group belonging to the subset of those with ESBL infections, 73 percent of the patients receiving cefepime and enmetazobactam achieved a clinical cure, as opposed to 51 percent of the patients on the standard therapy.

The antibiotic cefepime is a fourth-generation cephalosporin that was approved for use in the 1990s and is available generically. Enmetazobactam, an experimental drug made by the French biopharmaceutical company Allecra Therapeutics, is a beta-lactamase inhibitor, meaning it attacks the beta-lactamases, including the types of enzymes produced by ESBL-producing bacteria. The drug combination has been granted Qualified Infectious Disease Product and Fast Track designation by the U.S. Food and Drug Administration (FDA).

Kaye said he expected the company to apply for FDA approval early next year.

More than 2.8 million antimicrobial-resistant infections occur in the U.S. each year, and more than 35,000 people die from them, according to a report from the U.S. Centers for Disease Control and Prevention (CDC). In a 2019 study on antibiotic resistance, the CDC characterized ESBLs as a serious threat to human health. (ANI)

NRAI lauds Indian Army for initiating sustainable structured talent development program for girls in shooting sport discipline
Parliament intruder’s mother, sister claim his innocence, says he is getting framed, appeals for fair probe
Lt Governor Chairs Review Meeting of Industries & Commerce Department
First time, an all-women tri-services contingent taking part in parade”: Major General Sumit Mehta on Republic Day
“We promoted Make in India in every new technology”: PM Modi

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Whatsapp Whatsapp Copy Link Print
Previous Article Huge Public Participation witnessed in B2V4 at Shadab Karewa Shopian
Next Article PM Modi’s ‘Sab Ka Sath, Sab Ka Vikas, Sab Ka Vishwas’ made J&K “hub of tourism”: Tarun Chug
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

1MFollowersLike
262kFollowersFollow
InstagramFollow
234kSubscribersSubscribe
Google NewsFollow

Latest News

Japan to invest 10 trillion yen in India over next one decade
Top Stories
August 30, 2025
Rising Kashmir
50,000 ‘skilled, semi-skilled’ Indian personnel to be sent to Japan: MEA
Top Stories
August 30, 2025
HM Shah likely on two-day visit to Jammu from tomorrow
Top Stories
August 30, 2025
LG admin forms committee to investigate Shri Mata Vaishno Devi landslide
Top Stories
August 30, 2025

Recent Posts

  • Japan to invest 10 trillion yen in India over next one decade
  • 50,000 ‘skilled, semi-skilled’ Indian personnel to be sent to Japan: MEA
  • HM Shah likely on two-day visit to Jammu from tomorrow
  • LG admin forms committee to investigate Shri Mata Vaishno Devi landslide
  • All 34 victims identified, bodies handed over to families

Recent Comments

  1. Raja Mani Khan on Minor Girl Dies in J&K’s Poonch Landslide
  2. Raja Mani Khan on Srinagar: People gather in big numbers to participate in Muharram procession
  3. Shah on Relief for Employees: J&K Bank Fixes EMI-Credit Mismatch, says JK Bank Chairman
  4. Latif khan on Why Kashmir needs Stronger Private Healthcare and Health Insurance
  5. Sameer farooq mir on Qazi Irfan assumes charge as RTO Kashmir

Contact Us

Flat No 7,Press Enclave, Srinagar, 190001
0194 2477887
9971795706
[email protected]
[email protected]

Quick Link

  • E-Paper
  • About Us
  • Contact Us

Top Categories

Stay Connected

1.10MFollowersLike
305kFollowersFollow
344kFollowersFollow
2.9kSubscribersSubscribe
WhatsAppFollow
Copyright © Rising Kashmir
  • Home
  • Top Stories
  • News
  • National
  • Health
  • Anchor
  • Features
  • Interview
  • Video
  • Sports
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?